These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6662191)

  • 1. Kinetic properties of [3H]2-nitroimipramine binding to human platelets.
    Davis A
    Eur J Pharmacol; 1983 Dec; 96(1-2):105-10. PubMed ID: 6662191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]2-Nitroimipramine: a selective "slowly-dissociating" probe of the imipramine binding site ("serotonin transporter") in platelets and brain.
    Rehavi M; Tracer H; Rice K; Skolnick P; Paul SM
    Life Sci; 1983 Feb; 32(6):645-53. PubMed ID: 6835029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Nitroimipramine: a photoaffinity probe for the serotonin uptake/tricyclic binding site complex.
    Wennogle LP; Ashton RA; Schuster DI; Murphy RB; Meyerson LR
    EMBO J; 1985 Apr; 4(4):971-7. PubMed ID: 4018038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-nitroimipramine: a selective irreversible inhibitor of [3H] serotonin uptake and [3H] imipramine binding in platelets.
    Rehavi M; Ittah Y; Rice KC; Skolnick P; Goodwin FK; Paul SM
    Biochem Biophys Res Commun; 1981 Apr; 99(3):954-9. PubMed ID: 7247951
    [No Abstract]   [Full Text] [Related]  

  • 5. Nitroimipramines - synthesis and pharmacological effects of potent long-acting inhibitors of [3H] serotonin uptake and [3H] imipramine binding.
    Rehavi M; Ittah Y; Skolnick P; Rice KC; Paul SM
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Jul; 320(1):45-9. PubMed ID: 7121610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial characterization of solubilized platelet imipramine binding sites using a new probe, [3H]3-cyanoimipramine ([3H]Ro 11-2465).
    Davis A; Morris JM; Tang SW
    Eur J Pharmacol; 1985 Feb; 109(1):97-104. PubMed ID: 2986992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two affinity states for [3H]imipramine binding to the human platelet 5-hydroxytryptamine carrier: an explanation for the allosteric interaction between 5-hydroxytryptamine and imipramine.
    O'Riordan C; Phillips OM; Williams DC
    J Neurochem; 1990 Apr; 54(4):1275-80. PubMed ID: 2313287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative autoradiography of [3H]nitroimipramine binding sites in rat brain.
    Rainbow TC; Biegon A
    Brain Res; 1983 Mar; 262(2):319-22. PubMed ID: 6301637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine.
    D'Amato RJ; Largent BL; Snowman AM; Snyder SH
    J Pharmacol Exp Ther; 1987 Jul; 242(1):364-71. PubMed ID: 3475452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3H-imipramine binding and serotonin uptake in platelets from untreated depressed patients and control volunteers.
    Raisman R; Briley MS; Bouchami F; Sechter D; Zarifian E; Langer SZ
    Psychopharmacology (Berl); 1982; 77(4):332-5. PubMed ID: 6813892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Iodoimipramine, a novel ligand for the serotonin transporter.
    Humphreys CJ; Cassel D; Rudnick G
    Mol Pharmacol; 1989 Oct; 36(4):620-6. PubMed ID: 2811859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solubilization and assay of [3H]imipramine binding sites from human platelets.
    Davis A; Morris J; Tang SW
    Eur J Pharmacol; 1983 Jan; 86(3-4):353-9. PubMed ID: 6299755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity modulation of [3H]imipramine, [3H]paroxetine and [3H]citalopram binding to the 5-HT transporter from brain and platelets.
    Plenge P; Mellerup ET; Laursen H
    Eur J Pharmacol; 1991 Mar; 206(3):243-50. PubMed ID: 1830276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of [3H]Ro 11-2465. Possible identification of a subclass of [3H]imipramine binding sites.
    Dumbrille-Ross A; Tang SW
    Mol Pharmacol; 1983 May; 23(3):607-13. PubMed ID: 6306430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-methoxytryptoline and close analogs as candidates for the endogenous ligand of the 3H-imipramine recognition site.
    Langer SZ; Lee CR; Schoemaker H; Segonzac A; Esnaud H
    Prog Clin Biol Res; 1985; 192():441-55. PubMed ID: 3001765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased high affinity 3H-imipramine binding in platelets of enuretic children and adolescents.
    Weizman A; Carel C; Tyano S; Rehavi M
    Psychiatry Res; 1985 Jan; 14(1):39-46. PubMed ID: 3857647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant-binding sites in brain and platelets.
    Langer SZ; Galzin AM; Lee CR; Schoemaker H
    Ciba Found Symp; 1986; 123():3-29. PubMed ID: 3816412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temperature-sensitive conformational changes in membrane-bound and solubilized [3H]imipramine binding sites.
    Davis A; Morris JM; Tang SW
    Eur J Pharmacol; 1983 Apr; 88(4):407-10. PubMed ID: 6861879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin uptake inhibitors differentially modulate high affinity imipramine dissociation in human platelet membranes.
    Wennogle LP; Meyerson LR
    Life Sci; 1985 Apr; 36(16):1541-50. PubMed ID: 3982224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temperature-sensitive reversible loss of [3H]imipramine binding sites: evidence suggesting different conformational states.
    Dumbrille-Ross A; Morris J; Davis A; Tang SW
    Eur J Pharmacol; 1983 Aug; 91(4):383-9. PubMed ID: 6311587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.